Caitlin John’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Caitlin John's BMY Position: Q2 2026 in Review
Caitlin John reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2026, selling an estimated $55K and leaving 3,822 shares worth $220K. The position accounts for 0.12% of the portfolio, ranked #197.
Caitlin John first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $508K in Q3 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Caitlin John held 3,822 shares of Bristol-Myers Squibb worth $220K as of Q2 2026.
- Caitlin John sold 957 Bristol-Myers Squibb shares in Q2 2026, an estimated $55K.
- Bristol-Myers Squibb made up 0.12% of Caitlin John's portfolio in Q2 2026, its #197 holding.
- Caitlin John first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
- Caitlin John's Bristol-Myers Squibb position peaked at $508K in Q3 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.